ADMA BIOLOGICS, INC.

ADMANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$510.2M

▲ 19.6% YoY

Net Income

$146.9M

▼ 25.7% YoY

EPS

$0.60

▼ 25.9% YoY

Cash

$87.6M

▼ 15.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.